시장보고서 | 연간정보서비스 | 맞춤형시장조사 | 메일링 | 샘플 요청 목록
세계의 관절염용 윤활액 보충요법 시장 보고서(2025년)
Viscosupplementation Treatment For Arthritis Global Market Report 2025
상품코드 : 1889616
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 250 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ￦ 6,573,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ￦ 9,501,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ￦ 12,429,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

관절염용 윤활액 보충요법 시장 규모는 최근 현저한 성장을 보이고 있습니다. 2024년 38억 7,000만 달러에서 2025년에는 41억 8,000만 달러로, CAGR 7.8%로 확대되었습니다. 지난 수년간의 성장은 고령화에 따른 골관절염의 유병률 상승, 비외과적 치료 옵션에 대한 인지도 향상, 저침습 요법의 보급 확대, 주사 치료를 제공하는 정형외과 클리닉 증가, 전신적인 부작용이 없는 통증 완화를 선호하는 환자 경향 등에 의한 것으로 분석됩니다.

관절염용 윤활액 보충요법 시장 규모는 향후 수년간 강력한 성장이 예상됩니다. 2029년에는 55억 7,000만 달러에 달하고 CAGR은 7.5%를 나타낼 것으로 예측됩니다. 예측 기간 내 성장 요인으로서는 고령 인구 증가, 관절염 치료에서 조기 개입의 인지도 향상, 외래 및 가정 치료에 대한 수요 증가, 첨단 히알루론산 제제의 보급 확대, 임상시험 건수 증가를 들 수 있습니다. 예측 기간 동안 예상되는 주요 동향으로는 병용 요법의 개발, 원격 의료 플랫폼과의 통합, 서방형 제형의 진보, 재생 의료 접근법의 도입, 비용 효율적인 바이오시밀러 제품의 등장 등이 있습니다.

골관절염의 유병률 증가는 관절염용 윤활액 보충요법 시장의 성장을 이끌 것으로 예측됩니다. 골관절염은 연골의 점진적인 파괴를 특징으로 하는 만성 관절 질환으로, 통증, 경직, 가동 영역의 감소를 유발합니다. 골관절염 증례 증가는 관절의 자연적인 마모로 인해 노인이 걸리기 쉽기 때문에 주로 고령화 인구에 기인합니다. 윤활액 보충요법 치료는 관절의 윤활 기능을 회복시키고 통증을 완화하며 이동성을 개선하여 골관절염을 관리하는 데 도움이 됩니다. 예를 들어, 2025년 2월 영국 학술 출판사인 슈프링어 네이처 그룹(Springer Nature Group)이 추정한 바에 따르면 무릎 골관절염 환자 수는 남성 1,294만명, 여성 1,880만명이었습니다. 2046년까지 이 수치는 남성 1,845만명, 여성 2,560만명으로 증가할 것으로 예측됩니다. 이와 같이 변형성 관절증의 유병률 증가가 윤활액 보충요법 시장의 확대를 촉진하고 있습니다.

의료 지출 증가는 첨단 의료 서비스와 혁신에 대한 수요 증가로 시장 성장을 이끌 것으로 예측됩니다. 만성 질환의 유병률이 증가함에 따라 지속적인 의료 및 치료가 필요하기 때문에 의료 지출은 증가하는 추세에 있습니다. 이 지출은 첨단 치료에 대한 접근성 개선, 연구 개발에 대한 자금 제공, 골관절염 환자의 치료비 부담 경감을 통해 윤활액 보충요법 시장을 지원합니다. 예를 들어 2025년 6월 미국 의료보험 및 의료보조서비스센터(CMS)가 발표한 보고서에 따르면 2023년 국민의료지출(NHE)은 7.5% 증가하여 4조 9,000억 달러에 달했습니다. 이는 1인당 평균 1만 4,570달러에 해당하며 미국 GDP의 17.6%를 차지합니다. 메디케어 지출은 8.1% 증가하여 1조298억 달러에 이르렀으며 NHE 총액의 21%를 차지했습니다. 이러한 의료 지출 증가가 윤활액 보충요법 시장의 성장에 기여하고 있습니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁과 관세, 그리고 코로나 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별 및 국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 프로파일

제31장 기타 주요 기업 및 혁신 기업

제32장 세계 시장의 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장 잠재력이 높은 국가, 부문, 전략

제36장 부록

CSM
영문 목차

영문목차

Viscosupplementation treatment for arthritis is a medical therapy in which a gel-like substance, usually hyaluronic acid, is injected into a joint to enhance lubrication and reduce pain. This treatment helps restore the joint's natural cushioning and shock-absorbing abilities, particularly in osteoarthritis. It is often recommended when conventional treatments-such as pain relievers or physical therapy-are not sufficient to manage joint discomfort and stiffness.

The main product types of viscosupplementation treatment for arthritis include single injection, three injections, and five injections. Single-injection viscosupplementation refers to administering one dose of hyaluronic acid or a similar lubricant into the joint to relieve pain, improve mobility, and restore joint cushioning. These treatments are used for conditions such as knee osteoarthritis, hip osteoarthritis, shoulder osteoarthritis, and others, and are utilized by end users including hospitals, ambulatory surgical centers, orthopedic clinics, and other healthcare facilities.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.

The viscosupplementation treatment for arthritis market research report is one of a series of new reports from The Business Research Company that provides viscosupplementation treatment for arthritis market statistics, including viscosupplementation treatment for arthritis industry global market size, regional shares, competitors with a viscosupplementation treatment for arthritis market share, detailed viscosupplementation treatment for arthritis market segments, market trends and opportunities, and any further data you may need to thrive in the viscosupplementation treatment for arthritis industry. This viscosupplementation treatment for arthritis market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The viscosupplementation treatment for arthritis market size has grown strongly in recent years. It will grow from $3.87 billion in 2024 to $4.18 billion in 2025 at a compound annual growth rate (CAGR) of 7.8%. Growth during the historic period can be attributed to the rising prevalence of osteoarthritis among aging populations, increasing awareness of non-surgical treatment options, growing adoption of minimally invasive therapies, the expanding number of orthopedic clinics offering injections, and greater patient preference for pain relief without systemic side effects.

The viscosupplementation treatment for arthritis market size is expected to see strong growth in the next few years. It will grow to $5.57 billion in 2029 at a compound annual growth rate (CAGR) of 7.5%. Growth in the forecast period can be attributed to a growing elderly population, increasing awareness of early intervention in arthritis care, rising demand for outpatient and home-based treatments, wider adoption of advanced hyaluronic acid formulations, and an increasing number of clinical trials. Major trends expected in the forecast period include the development of combination therapies, integration with telemedicine platforms, advancements in sustained-release formulations, incorporation of regenerative medicine approaches, and the emergence of cost-effective biosimilar products.

The increasing prevalence of osteoarthritis is expected to drive the growth of the viscosupplementation treatment market for arthritis. Osteoarthritis is a chronic joint condition marked by the gradual breakdown of cartilage, leading to pain, stiffness, and reduced mobility. The rise in osteoarthritis cases is largely attributed to an aging population, as the natural wear and tear of joints makes older adults more prone to the condition. Viscosupplementation treatments help manage osteoarthritis by restoring joint lubrication, easing pain, and improving mobility. For example, in February 2025, Springer Nature Group, a UK-based academic publisher, estimated that there were 12.94 million cases of knee osteoarthritis in men and 18.80 million in women. By 2046, these figures are expected to rise to 18.45 million in men and 25.60 million in women. As such, the growing prevalence of osteoarthritis is fueling the expansion of the viscosupplementation treatment market.

The increasing healthcare expenditure is expected to drive market growth due to the rising demand for advanced medical services and technological innovations. Healthcare spending is growing because of the higher prevalence of chronic diseases, which require ongoing medical care and treatments. This spending supports the viscosupplementation treatment market by improving access to advanced therapies, funding research and development, and making treatments more affordable for patients managing osteoarthritis. For instance, in June 2025, the Centers for Medicare & Medicaid Services (CMS) reported that in 2023, national health expenditures (NHE) increased by 7.5% to reach $4.9 trillion, averaging $14,570 per person and representing 17.6% of the U.S. GDP. Medicare spending rose by 8.1% to $1,029.8 billion, accounting for 21% of the total NHE. As a result, rising healthcare expenditure is contributing to the growth of the viscosupplementation treatment market.

Major players in the viscosupplementation treatment market are focused on developing innovative solutions, such as advanced hyaluronic acid formulations, to improve joint lubrication, reduce pain, and enhance mobility for musculoskeletal conditions. These enhanced hyaluronic acid formulations are designed with an optimized molecular structure and viscosity to provide longer-lasting lubrication and more effective pain relief in arthritis treatments. For example, in February 2024, IBSA Group, a Switzerland-based pharmaceutical company, launched the SINOVIAL range, a next-generation viscosupplementation treatment. This range uses NAHYCO technology, which combines high and low molecular weight hyaluronic acid to offer effective joint lubrication and extended pain relief. These treatments mimic the functions of natural synovial fluid, improving joint cushioning and shock absorption. The injectable formulations provide optimal viscosity and excellent patient tolerance, enhancing comfort, mobility, and osteoarthritis management.

Major companies operating in the viscosupplementation treatment for arthritis market are Johnson And Johnson, Sanofi S.A., LG Chem Ltd., Teva Pharmaceutical Industries Ltd., Chugai Pharmaceutical Co. Ltd., Zimmer Biomet Holdings Inc., Singapore Health Services Pte Ltd., IBSA Group, Bioventus LLC, Fidia Farmaceutici S.p.A., Ferring Pharmaceuticals A/S, Anika Therapeutics Inc., TRB Chemedica International S.A., Laboratoires VIVACY, Seikagaku Corporation, Regen Lab SA, OrthogenRx Inc., Wellchem Pharmaceuticals Pte Ltd., Shanghai Haohai Biological Technology Co. Ltd., Miravo Healthcare.

North America was the largest region in the viscosupplementation treatment for arthritis market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in viscosupplementation treatment for arthritis report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the viscosupplementation treatment for arthritis market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The viscosupplementation treatment for arthritis market consists of revenues earned by entities by providing services such as joint assessment and imaging services, physical therapy support, post-injection monitoring and follow-up, arthroscopic guidance services, and customized treatment planning. The market value includes the value of related goods sold by the service provider or included within the service offering. The viscosupplementation treatment market also includes sales of hyaluronic acid injections, cross-linked hyaluronic acid formulations, multi-dose hyaluronic acid syringes, combination therapies, and biologically derived viscosupplements. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Viscosupplementation Treatment For Arthritis Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on viscosupplementation treatment for arthritis market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for viscosupplementation treatment for arthritis ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The viscosupplementation treatment for arthritis market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

Scope

Table of Contents

1. Executive Summary

2. Viscosupplementation Treatment For Arthritis Market Characteristics

3. Viscosupplementation Treatment For Arthritis Market Trends And Strategies

4. Viscosupplementation Treatment For Arthritis Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Viscosupplementation Treatment For Arthritis Growth Analysis And Strategic Analysis Framework

6. Viscosupplementation Treatment For Arthritis Market Segmentation

7. Viscosupplementation Treatment For Arthritis Market Regional And Country Analysis

8. Asia-Pacific Viscosupplementation Treatment For Arthritis Market

9. China Viscosupplementation Treatment For Arthritis Market

10. India Viscosupplementation Treatment For Arthritis Market

11. Japan Viscosupplementation Treatment For Arthritis Market

12. Australia Viscosupplementation Treatment For Arthritis Market

13. Indonesia Viscosupplementation Treatment For Arthritis Market

14. South Korea Viscosupplementation Treatment For Arthritis Market

15. Western Europe Viscosupplementation Treatment For Arthritis Market

16. UK Viscosupplementation Treatment For Arthritis Market

17. Germany Viscosupplementation Treatment For Arthritis Market

18. France Viscosupplementation Treatment For Arthritis Market

19. Italy Viscosupplementation Treatment For Arthritis Market

20. Spain Viscosupplementation Treatment For Arthritis Market

21. Eastern Europe Viscosupplementation Treatment For Arthritis Market

22. Russia Viscosupplementation Treatment For Arthritis Market

23. North America Viscosupplementation Treatment For Arthritis Market

24. USA Viscosupplementation Treatment For Arthritis Market

25. Canada Viscosupplementation Treatment For Arthritis Market

26. South America Viscosupplementation Treatment For Arthritis Market

27. Brazil Viscosupplementation Treatment For Arthritis Market

28. Middle East Viscosupplementation Treatment For Arthritis Market

29. Africa Viscosupplementation Treatment For Arthritis Market

30. Viscosupplementation Treatment For Arthritis Market Competitive Landscape And Company Profiles

31. Viscosupplementation Treatment For Arthritis Market Other Major And Innovative Companies

32. Global Viscosupplementation Treatment For Arthritis Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Viscosupplementation Treatment For Arthritis Market

34. Recent Developments In The Viscosupplementation Treatment For Arthritis Market

35. Viscosupplementation Treatment For Arthritis Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기